Novogene Co., Ltd. (688315.SS)

CNY 13.46

(-0.15%)

Total Assets Summary of Novogene Co., Ltd.

  • Novogene Co., Ltd.'s latest annual total assets in 2023 was 3.59 Billion CNY , up 17.92% from previous year.
  • Novogene Co., Ltd.'s latest quarterly total assets in 2024 Q2 was 3.38 Billion CNY , down -2.15% from previous quarter.
  • Novogene Co., Ltd. reported annual total assets of 3.04 Billion CNY in 2022, up 6.61% from previous year.
  • Novogene Co., Ltd. reported annual total assets of 2.85 Billion CNY in 2021, up 41.22% from previous year.
  • Novogene Co., Ltd. reported quarterly total assets of 3.48 Billion CNY for 2024 Q3, up 2.74% from previous quarter.
  • Novogene Co., Ltd. reported quarterly total assets of 3.46 Billion CNY for 2024 Q1, down -3.68% from previous quarter.

Annual Total Assets Chart of Novogene Co., Ltd. (2023 - 2015)

Historical Annual Total Assets of Novogene Co., Ltd. (2023 - 2015)

Year Total Assets Total Assets Growth
2023 3.59 Billion CNY 17.92%
2022 3.04 Billion CNY 6.61%
2021 2.85 Billion CNY 41.22%
2020 2.02 Billion CNY 2.77%
2019 1.97 Billion CNY 33.9%
2018 1.47 Billion CNY 8.78%
2017 1.35 Billion CNY 10.23%
2016 1.22 Billion CNY 155.59%
2015 480.08 Million CNY 0.0%

Peer Total Assets Comparison of Novogene Co., Ltd.

Name Total Assets Total Assets Difference
Beijing Tiantan Biological Products Co., Ltd. 14.18 Billion CNY 74.666%
JiangSu WuZhong Pharmaceutical Development Co., Ltd. 4.32 Billion CNY 16.928%
Jinyu Bio-technology Co., Ltd. 6.87 Billion CNY 47.699%
Vcanbio Cell & Gene Engineering Corp., Ltd 5.41 Billion CNY 33.576%
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong 14.38 Billion CNY 75.012%
Zhejiang Ausun Pharmaceutical Co., Ltd. 2.95 Billion CNY -21.78%
DaShenLin Pharmaceutical Group Co., Ltd. 24.12 Billion CNY 85.1%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. 15.71 Billion CNY 77.127%
GuiZhou SanLi Pharmaceutical Co.,Ltd 2.92 Billion CNY -23.078%
Pulike Biological Engineering, Inc. 3.26 Billion CNY -10.184%
Beijing Konruns Pharmaceutical Co.,Ltd. 3.78 Billion CNY 4.93%
Shanghai Hile Bio-Technology Co., Ltd. 1.65 Billion CNY -116.825%
Qingdao Vland Biotech INC. 3.03 Billion CNY -18.469%
Zhejiang Shouxiangu Pharmaceutical Co., Ltd. 3.17 Billion CNY -13.233%
Aurisco Pharmaceutical Co.,Ltd. 2.57 Billion CNY -39.61%
Zhejiang East Asia Pharmaceutical Co., Ltd. 3.34 Billion CNY -7.51%
Hainan Huluwa Pharmaceutical Group Co., Ltd. 3.06 Billion CNY -17.444%
Mabwell (Shanghai) Bioscience Co., Ltd. 4.45 Billion CNY 19.318%
Beijing Hotgen Biotech Co., Ltd. 3.56 Billion CNY -0.95%
Assure Tech (Hangzhou) Co., Ltd. 5.78 Billion CNY 37.915%
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. 3.54 Billion CNY -1.33%
Cabio Biotech (Wuhan) Co., Ltd. 1.61 Billion CNY -123.049%
Shanghai Shen Lian Biomedical Corporation 1.59 Billion CNY -125.498%
Nanjing Vazyme Biotech Co., Ltd. 5.74 Billion CNY 37.447%
Shandong Kexing Bioproducts Co,.Ltd 3.03 Billion CNY -18.585%
Shanghai Junshi Biosciences Co., Ltd. 11.34 Billion CNY 68.311%
Shanghai Model Organisms Center, Inc. 1.99 Billion CNY -79.922%
Suzhou Zelgen Biopharmaceuticals Co., Ltd. 2.88 Billion CNY -24.495%
Xiamen Amoytop Biotech Co., Ltd. 2.35 Billion CNY -52.559%
Shanghai ZJ Bio-Tech Co., Ltd. 4.07 Billion CNY 11.776%
Chengdu Olymvax Biopharmaceuticals Inc. 1.61 Billion CNY -122.895%
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd 5.3 Billion CNY 32.245%
Shanghai Haohai Biological Technology Co., Ltd. 7.1 Billion CNY 49.414%
Jiangsu Bioperfectus Technologies Co., Ltd. 3.9 Billion CNY 7.987%
Jiangsu Aidea Pharmaceutical Co., Ltd. 1.74 Billion CNY -105.799%
Chengdu Easton Biopharmaceuticals Co., Ltd. 3.34 Billion CNY -7.4%
Sinocelltech Group Limited 2.71 Billion CNY -32.219%
Wuhan Keqian Biology Co.,Ltd 4.67 Billion CNY 23.052%
Shanghai Allist Pharmaceuticals Co., Ltd. 4.37 Billion CNY 17.87%
Anhui Huaheng Biotechnology Co., Ltd. 3.97 Billion CNY 9.466%
Youcare Pharmaceutical Group Co., Ltd. 5.91 Billion CNY 39.194%
Jiangsu gdk Biotechnology Co., Ltd. 1.63 Billion CNY -120.3%
Beijing Kawin Technology Share-Holding Co., Ltd. 2.44 Billion CNY -46.818%
Hangzhou Biotest Biotech Co.,Ltd. 2.57 Billion CNY -39.342%